| RS2528740086 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528740117 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528740212 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528740235 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528740269 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528740277 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528740306 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528740471 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528742818 |
AGXT
|
Health Risk |
Likely pathogenic |
— |
| RS2528742910 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528742931 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528742947 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528744114 |
AGXT
|
Health Risk |
Likely pathogenic |
— |
| RS2528744408 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528744495 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528744521 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528744782 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528744859 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528747575 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528748371 |
MSH2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528748953 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528749097 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528749129 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms |
| RS2528749626 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528749663 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528749665 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colon cancer |
| RS2528749754 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528749898 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528749940 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528750839 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528751087 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528751309 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528751586 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528751739 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2528752106 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528753115 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528753200 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528753217 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528753308 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528753326 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528753327 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528753335 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528753984 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS2528754380 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary cancer-predisposing syndrome |
| RS2528754530 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528754604 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528754713 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528754973 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528755898 |
LARS2
|
Health Risk |
Pathogenic |
— |
| RS2528755914 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528755991 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528756014 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528756053 |
AGXT
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type I |
| RS2528756084 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528756219 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528756250 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528756764 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS2528756925 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528757801 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528758264 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528758305 |
PI4KB
|
Health Risk |
Pathogenic |
Hearing loss, autosomal dominant 87 |
| RS2528758339 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528758393 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528758415 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528758487 |
MSH2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528758651 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528758741 |
MSH2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528760002 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS2528762183 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528762537 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528764075 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528764137 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528764378 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528766258 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528766265 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528766345 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528766485 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS2528766539 |
AGXT
|
Health Risk |
Pathogenic |
— |
| RS2528766716 |
AGXT
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type I |
| RS2528777422 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2528780273 |
ACBD6
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with progressive movement abnormalities, Neurodevelopmental disorder with progressive movement abnormalities |
| RS2528783505 |
METTL5
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal recessive 72 |
| RS2528784290 |
METTL5
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal recessive 72 |
| RS2528785092 |
ABHD5
|
Health Risk |
Likely pathogenic |
Triglyceride storage disease with ichthyosis, Triglyceride storage disease with ichthyosis |
| RS2528785198 |
ABHD5
|
Health Risk |
Pathogenic |
Triglyceride storage disease with ichthyosis, Triglyceride storage disease with ichthyosis |
| RS2528785565 |
ABHD5
|
Health Risk |
Likely pathogenic |
— |
| RS2528785906 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS2528786590 |
CACNA1E
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 69 |
| RS2528786778 |
METTL5
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 72 |
| RS2528802018 |
TRAPPC12
|
Health Risk |
Likely pathogenic |
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome, Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome |
| RS2528806737 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2528806832 |
LARS2
|
Health Risk |
Pathogenic |
— |
| RS2528811007 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2528816473 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2528822984 |
PPP1R21
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, facial dysmorphism |
| RS2528828282 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528828557 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528828762 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528828987 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528829152 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |